Table 2 Radiation Treatment Details
From: Capecitabine and stereotactic radiation in the management of breast cancer brain metastases
Variable | n | % |
|---|---|---|
Technique | ||
 SRS | 80 | 89% |
 FSRT | 10 | 11% |
SRS Dose (Gy) | ||
 Median (range) | 21 (15–24) |  |
FSRT Dose (Gy) | ||
 Median (range) | 25 (24–30) |  |
 Fractions | 5 (3–5) |  |
Postoperative Cavity | 7 | 8% |
PTV (cm3) | ||
 Median (range) | 0.71 (0.012–39.1) |  |